Sapiens Reports First Quarter 2018 Financial Results

HOLON, Israel, May 7, 2018 /PRNewswire/ -- Sapiens International Corporation, (NASDAQ: SPNS) (TASE: SPNS), a leading global provider of software solutions for the insurance industry, and a member of the Formula Group (NASDAQ: FORTY) (TASE: FORTY), today announced its financial results for the first quarter ended March 31, 2018.

Sapiens Logo

First Quarter 2018 Highlights:

  • Revenue totaled $71.0 million an increase of 25.6% compared to last year.
    Non-GAAP revenue increased 25.7% from the same period in the prior year to $71.1 million.
  • Operating income totaled $4.7 million, up from ($1.6) million last year. Non-GAAP operating income totaled $8.9 million, up from $1.7 million the same period in the prior year.
  • Operating margin of 6.6%, compared to negative margin last year. Non-GAAP operating margin of 12.5%, compared to 3.0% last year.
  • Net income attributable to Sapiens' shareholders totaled $2.8 million. Non-GAAP net income attributable to Sapiens' shareholders totaled $6.3 million, compared to $1.2 in the same period last year.
  • Diluted earnings per share of $0.06. Non-GAAP diluted earnings per share of $0.13 per diluted share, compared to $0.02 in the same period in the prior year.
  • Cash and cash equivalents totaled $61.7 million.

 

"In the first quarter we advanced the execution of our long-term strategy to be a leading provider of insurance software solutions and services around the globe. Last year we improved our competitive position through both organic product and solution development, and acquisitions in focused growth markets, particularly in Europe and North America. Now that we are fully integrated, we are realizing deal synergies, and maximizing our acquired talent. We are well positioned to help our customers capitalize on current and future insurance trends, namely digitalization, data analytics, and legacy transformation," said Roni Al-Dor, president and CEO, Sapiens.

"Revenues were above the high end of our guidance range in the first quarter, and we improved profitability year-over-year. The first quarter Non-GAAP operating margin of 12.5% was above our guidance of 10%," concluded Roni Al-Dor. "We remain on track to improve operating margins throughout 2018 and reiterate our 2018 Non-GAAP operating margin guidance of 12% to 13% with revenue in the range of $280-$285 million (on a non-GAAP basis)."

Quarterly Results Conference Call

Management will host a conference call and webcast on May 7, 2018 at 9:30 a.m. Eastern Time (4:30 p.m. in Israel) to review and discuss Sapiens' results.

Please call the following numbers (at least 10 minutes before the scheduled time) to participate:

North America (toll-free): + 1-888-407-2553; International: +972-3-918-0610; UK: 0-800-917-5108

The live webcast of the call can be viewed on Sapiens' website at: http://www.sapiens.com/investors/presentations-and-webcast/

If you are unable to join live, a replay of the call will be accessible until May 15, 2018, as follows:

North America: 1-888-782-4291; International: +972-3-925-5918

A recorded version of the webcast will also be available via the Sapiens website, for three months at the same location.

Non-GAAP Financial Measures

This press release contains the following non-GAAP financial measures: non-GAAP revenue, non-GAAP gross profit, non-GAAP operating income, non-GAAP net income attributed to Sapiens shareholders, and non-GAAP basic and diluted earnings per share.

Sapiens believes that these non-GAAP measures of financial results provide useful information to management and investors regarding certain financial and business trends relating to Sapiens' financial condition and results of operations. The Company's management uses these non-GAAP measures to compare the Company's performance to that of prior periods for trend analyses, for purposes of determining executive and senior management incentive compensation and for budgeting and planning purposes. These measures are used in financial reports prepared for management and in quarterly financial reports presented to the Company's board of directors. The Company believes that the use of these non-GAAP financial measures provides an additional tool for investors to use in evaluating ongoing operating results and trends, and in comparing the Company's financial measures with other software companies, many of which present similar non-GAAP financial measures to investors.

Non-GAAP financial measures consist of GAAP financial measures adjusted to exclude: Valuation adjustment on acquired deferred revenue, amortization of intangible assets, capitalization of software development, stock-based compensation, compensation related to acquisition and acquisition-related costs, restructuring and cost reduction costs, loss on sales of Marketable Securities and tax adjustment regarding non-GAAP adjustments, as well as the impact of one-time adjustment to our deferred taxes as a result of the U.S. Tax Cuts and Job act 2017.

Management of the Company does not consider these non-GAAP measures in isolation, or as an alternative to financial measures determined in accordance with GAAP. The principal limitation of these non-GAAP financial measures is that they exclude significant expenses and income that are required by GAAP to be recorded in the Company's financial statements. In addition, they are subject to inherent limitations, as they reflect the exercise of judgment by management about which expenses and income are excluded or included in determining these non-GAAP financial measures.

To compensate for these limitations, management presents non-GAAP financial measures in connection with GAAP results. Sapiens urges investors to review the reconciliation of its non-GAAP financial measures to the comparable GAAP financial measures, which it includes in press releases announcing quarterly financial results, including this press release, and not to rely on any single financial measure to evaluate the Company's business.

Reconciliation tables of the most comparable GAAP financial measures to the non-GAAP financial measures used in this press release are included with the financial tables of this release.

The Company defines Adjusted EBITDA as net profit, adjusted for valuation adjustment on acquired deferred revenue, stock-based compensation expense, depreciation and amortization, capitalized of software development costs, compensation expenses related to acquisition and acquisition-related costs, restructuring and cost reduction costs, financial expense (income), provision for income taxes and other income (expenses). These amounts are often excluded by other companies to help investors understand the operational performance of their business.

The Company uses Adjusted EBITDA as a measurement of its operating performance, because it assists in comparing the operating performance on a consistent basis by removing the impact of certain non-cash and non-operating items. Adjusted EBITDA reflects an additional way of viewing aspects of the operations that the Company believes, when viewed with the GAAP results and the accompanying reconciliations to corresponding GAAP financial measures, provide a more complete understanding of factors and trends affecting its business.

About Sapiens

Sapiens International Corporation is a leading global provider of software solutions for the insurance industry, with a 30-year track record of delivering to more than 400 organizations. The company offers software platforms, solutions and services, including a full digital suite, to satisfy the needs of property and casualty/general insurers, and life, pension and annuity providers. Sapiens also services the reinsurance, workers' compensation, financial and compliance, and decision management markets.

The company's portfolio includes policy administration, billing and claims, underwriting, illustration and electronic application. The digital suite features customer and agent portals, and a business intelligence platform. For more information: www.sapiens.com.

Forward Looking Statement

Some of the statements in this press release may constitute "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, Section 21E of the Securities and Exchange Act of 1934 and the United States Private Securities Litigation Reform Act of 1995. Words such as "will," "expects," "believes" and similar expressions are used to identify these forward-looking statements (although not all forward-looking statements include such words). These forward-looking statements, which may include, without limitation, projections regarding our future performance and financial condition, are made on the basis of management's current views and assumptions with respect to future events. Any forward-looking statement is not a guarantee of future performance and actual results could differ materially from those contained in the forward-looking statement.

These statements speak only as of the date they were made, and we undertake no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. We operate in a changing environment. New risks emerge from time to time and it is not possible for us to predict all risks that may affect us. For more information regarding these risks and uncertainties, as well as certain additional risks that we face, please refer to the Risk Factors detailed in Item 3 of Part III of our Annual Report on Form 20-F for the year ended December 31, 2017, and subsequent reports and registration statements filed from time to time with the Securities and Exchange Commission.

 

 

SAPIENS INTERNATIONAL CORPORATION N.V. AND ITS SUBSIDIARIES             

CONDENSED CONSOLIDATED STATEMENTS OF INCOME    

U.S. dollars in thousands (except per share amounts)





  Three months ended




 March 31,




2018


2017




(unaudited)


 (unaudited)







 Revenue


70,995


56,534

 Cost of revenue


43,967


37,388







 Gross profit


27,028


19,146







 Operating expenses:






 Research and development, net


9,147


6,195


 Selling, marketing, general and administrative


13,184


14,588

 Total operating expenses


22,331


20,783







 Operating income (loss)


4,697


(1,637)







 Financial expense, net


838


438

 Taxes and other expenses, net


1,031


167







 Net income (loss)


2,828


(2,242)







 Attributed to non-controlling interest


(8)


(30)







 Net income (loss) attributable to Sapiens' shareholders


2,836


(2,212)

 

 

 

Basic earnings (loss) per share


0.06


(0.05)







 Diluted earnings (loss) per share


0.06


(0.05)







 Weighted average number of shares outstanding used

  to compute basic earnings per share (in thousands)


49,773


49,047






 Weighted average number of shares outstanding used

 to compute diluted earnings per share (in thousands)


50,070


49,047

 

 

SAPIENS INTERNATIONAL CORPORATION N.V. AND ITS SUBSIDIARIES                

CONDENSED CONSOLIDATED NON-GAAP STATEMENTS OF INCOME            

U.S. dollars in thousands (except per share amounts)





  Three months ended




March 31,




2018


2017




(unaudited)


 (unaudited)







 Revenue


71,085


56,534

 Cost of revenue


40,801


36,064







 Gross profit


30,284


20,470







 Operating expenses:






 Research and development, net


10,324


7,260


 Selling, marketing, general and administrative


11,097


11,512

 Total operating expenses


21,421


18,772







 Operating income


8,863


1,698







 Financial expense, net


838


208

 Taxes and other expenses


1,726


336







 Net income


6,299


1,154







 Attributable to non-controlling interest


(8)


(30)







 Net income attributable to Sapiens' shareholders


6,307


1,184













 Basic earnings per share


0.13


0.02







 Diluted earnings per share


0.13


0.02












Weighted average number of shares outstanding used
to compute basic earnings per share (in thousands)


49,773


49,047






Weighted average number of shares outstanding used
to compute diluted earnings per share (in thousands)


50,070


49,998


 

 

SAPIENS INTERNATIONAL CORPORATION N.V. AND SUBSIDIARIES 

RECONCILIATION OF GAAP TO NON-GAAP RESULTS

U.S. dollars in thousands (except per share amounts)




Three months ended



March 31,



2018


2017



(unaudited)


(unaudited)






GAAP revenue


70,995


56,534

Valuation adjustment on acquired deferred revenue


90


-

Non-GAAP revenue


71,085


56,534











GAAP gross profit


27,028


19,146

Valuation adjustment on acquired deferred revenue


90


-

Amortization of capitalized software


1,255


1,021

Amortization of other intangible assets


1,911


303

Non-GAAP gross profit


30,284


20,470






GAAP operating income (loss)


4,697


(1,637)

Gross profit adjustments


3,256


1,324

Capitalization of software development


(1,177)


(1,065)

Amortization of other intangible assets


922


951

Stock-based compensation


587


455

Compensation related to acquisition and acquisition-related costs


578


1,670

Non-GAAP operating income


8,863


1,698






  GAAP net income (loss) attributable to Sapiens' shareholders


2,836


(2,212)

  Operating income adjustments


4,166


3,335

  Loss on sales of Marketable Securities


-


230

  Tax and other


(695)


(169)

  Non-GAAP net income attributable to Sapiens'   shareholders


6,307


1,184


 

 

Summary of NON-GAAP Financial Information

U.S. dollars in thousands (except per share amounts)



Three months ended


March 31,


2018


2017


(unaudited)


(unaudited)







Revenues

71,085

100%


56,534

100%

Gross profit

30,284

42.6%


20,470

36.2%

Operating income

8,863

12.5%


1,698

3.0%

Net income attributable to Sapiens' shareholders

6,307

8.9%


1,184

2.1%

Adjusted EBITDA

9,945

14.0%


2,574

4.6%







Basic earnings per share

0.13



0.02


Diluted earnings per share

0.13



0.02


 

 


 

Non-GAAP Revenues by Geographic Breakdown

U.S. dollars in thousands



Q1 2018


Q4 2017


Q3 2017


Q2 2017


Q1 2017











North America

31,035


31,580


32,780


28,544


19,465

Europe

34,479


29,789


28,984


31,418


30,735

Asia Pacific

3,439


3,817


5,750


3,912


4,580

South Africa

2,132


7,262


6,340


5,293


1,754











Total

71,085


72,448


73,854


69,167


56,534


 


 

 

Adjusted EBITDA Calculation

U.S. dollars in thousands




Three months ended



 March 31,



2018


2017



(unaudited)


(unaudited)






GAAP operating income(loss)


4,697


(1,637)






Non-GAAP adjustments:





Valuation adjustment on acquired
  deferred revenue


90


-

Amortization of capitalized software


1,255


1,021

Amortization of other intangible assets


2,833


1,254

Capitalization of software development


(1,177)


(1,065)

Stock-based compensation


587


455

Compensation related to acquisition and
  acquisition-related costs


578


1,670






Non-GAAP operating income


8,863


1,698






Depreciation


1,082


876






Adjusted EBITDA


9,945


2,574


 

 

SAPIENS INTERNATIONAL CORPORATION N.V. AND ITS SUBSIDIARIES

CONDENSED CONSOLIDATED BALANCE SHEETS

U.S. dollars in thousands





March 31,


December 31,




2018


2017




 (unaudited)


 (unaudited)







 ASSETS











 CURRENT ASSETS






Cash and cash equivalents


61,749


71,467


Trade receivables, net


53,346


53,226


Other receivables and prepaid expenses


7,534


6,280








Total current assets


122,629


130,973







 LONG-TERM ASSETS






Property and equipment, net


10,163


10,695


Severance pay fund


4,559


4,547


Goodwill and intangible assets, net


242,062


223,729


Other long-term assets


4,514


3,675








Total long-term assets


261,298


242,646







 TOTAL ASSETS


383,927


373,619







LIABILITIES AND EQUITY











 CURRENT LIABILITIES






Trade payables


5,656


7,044


Current maturities of Series B Debentures


9,898


-


Accrued expenses and other liabilities


48,144


46,612


Deferred revenue


20,228


16,513








Total current liabilities


83,926


70,169







 LONG-TERM LIABILITIES






Series B Debentures, net of current maturities


68,427


78,281


Deferred tax liabilities


10,948


9,171


Other long-term liabilities


7,850


8,271


Accrued severance pay


5,633


5,500








Total long-term liabilities


92,858


101,223













REDEEMABLE NON-CONTROLLING INTEREST


1,353


1,353







EQUITY


205,790


200,874







TOTAL LIABILITIES AND EQUITY


383,927


373,619

 


 

 

SAPIENS INTERNATIONAL CORPORATION N.V. AND ITS SUBSIDIARIES

CONSOLIDATED STATEMENT OF CASH FLOW

U.S. dollars in thousands



For the three months ended March 31,


2018

2017


(unaudited)

(unaudited)

 

Cash flows from operating activities:



Net income (loss)

2,828

(2,242)

Reconciliation of net income (loss) to net cash provided by
 (used in) operating

activities:



Depreciation and amortization

5,170

3,151

Amortization of premium, accrued interest and
  loss on sales of marketable securities

-

509

Stock-based compensation related to options issued
  to employees

588

455




Net changes in operating assets and liabilities, net of
 amount acquired:



Trade receivables

1,664

(10,510)

Deferred tax assets

(1,163)

(1,009)

Other operating assets

(1,000)

681

Trade payables

(3,013)

(771)

Other operating liabilities

(1,138)

908

Deferred revenues

4,729

1,556

Severance pay

127

(49)




Net cash provided by (used in) operating activities

8,792

(7,321)




Cash flows from investing activities:



Purchase of property and equipment

(477)

(580)

Proceeds from sales of marketable securities

-

35,369

Payments for business acquisition, net of cash
  acquired

(17,893)

(94,111)

Capitalized software development costs

(1,177)

(1,065)




Net cash used in investing activities

(19,547)

(60,387)




Cash flows from financing activities:



Proceeds from employee stock options exercised

10

110

Loan received, net of repayment of loan

(18)

39,987

Dividend to non-controlling interest

(47)

-




Net cash provided by (used in) financing activities

(55)

40,097




Effect of exchange rate changes on cash and cash equivalents

1,092

1,818




Increase in cash and cash equivalents

(9,718)

(25,793)

Cash and cash equivalents at the beginning of period

71,467

60,908




Cash and cash equivalents at the end of period

61,749

35,115

 

Debentures Covenants

As of March 31, 2018, Sapiens was in compliance with all of its financial covenants under the indenture for the Series B Debentures that it issued in September 2017, based on having achieved the following in its consolidated financial results:

Covenant 1

  • Target shareholders' equity (excluding minority interest): above $120 million.
  • Actual shareholders' equity equal to $206 million.

Covenant 2

  • Target ratio of net financial indebtedness to net capitalization (in each case, as defined under the indenture for the Company's Series B Debentures) bellow 65%.
  • Actual ratio of net financial indebtedness to net capitalization equal to 7.45%.

 

Investors and Media Contact
Yaffa Cohen-Ifrah
Chief Marketing Officer and Head of Corporate Communications
Sapiens International
U.S. Mobile: +1 201-250-9414
Mobile: +972 54-9099039
Email: yaffa.cohen-ifrah@sapiens.com

Cision View original content:http://www.prnewswire.com/news-releases/sapiens-reports-first-quarter-2018-financial-results-300643443.html

SOURCE Sapiens International Corporation